Table 1 Validation samples used to test the 13-gene miRNA predictor

From: A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT

Cell lines/tumour

Actual sensitivity

Predicted sensitivity

Lung-2122

Sensitive (S)

Resistant (R)

Lung-827

S

R

Lung-322

S

R

Lung-820

R

S

Pancreatic-Aspc1

S

S

Pancreatic-Bxpc1

S

S

Pancreatic-MiaPaca

R

R

Pancreatic-Panc1

R

R

Primary tumours-lung A

S

S

Primary tumours-lung B

R

R

Primary tumours-lung C

R

R

Primary tumours-lung D

R

R

Met-U38-lung

R

R

Met U39-lung

R

R

Met U40-lung

S

S

Met U41-colorectal

S

R

  1. Eight cell lines and eight tumours were used to prepare RNA for generation of miRNA expression data. Actual sample sensitivity is noted in column 2, and predicted sensitivity is shown in column 3.
Back to article page